Skip to content

Almond Intervention in Type 2 Diabetes Mellitus

Effect of Almond Supplementation on Glycemic and Cardiovascular Risk Factors in Asian Indians in North India With Type 2 Diabetes Mellitus: A 24-week Prospective Cohort Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02027740
Enrollment
50
Registered
2014-01-06
Start date
2009-01-31
Completion date
2013-02-28
Last updated
2014-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Brief summary

This prospective cohort study of an almond-enriched diet (within the overall context of Asian Indian dietary guidelines) was conducted to test the hypothesis that in patients with T2DM almond-enriched balanced diet improves glycemic measures and CVD risk factors.

Interventions

DIETARY_SUPPLEMENTalmond

Sponsors

Diabetes Foundation, India
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients in the age range of 25-65 years * on stable doses of metformin from past 3 months * having HbA1C less than 9% * LDL-c ≥100 mg/dl were recruited

Exclusion criteria

* Patients on insulin therapy, plioglitazone, insulin secretagogues, beta blockers or steroids or suffering from diabetes for more than 10 years * having high uric acid levels (≥ 8 mg/dl), * with accelerated hypertension (stage 2 hypertension according to JNC guidelines) , hypothyroidism, suffering from acute infection or any debilitating disease or with renal failure, * appreciable weight loss (more than 10%) during past 6 months * Patients with known food allergy, lipid altering medication or extraneous factors that can affect glycemic or lipid parameters

Design outcomes

Primary

MeasureTime frame
Change in LDL-cbaseline, after six months

Secondary

MeasureTime frame
HbA1Cbaseline, after six months of intervention

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026